Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 52
Filter
1.
Ann Thorac Cardiovasc Surg ; 13(1): 50-2, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17392673

ABSTRACT

A 68-year-old man with recurrent bilateral severe pneumonia and invasive thymic carcinoma was admitted to our hospital. An extended thymo-thymectomy with lymph nodes dissection was performed for an irregular shaped anterior mediastinum mass. The tumor was mainly composed of type C, adenosquamous carcinoma, and found to have a small area of types B2 and B3 thymoma. History and laboratory findings were compatible with the diagnosis of Good syndrome. Although there are some reports of thymic carcinoma arising from thymoma, this is the first report of co-existence of adenosquamous carcinomas and thymoma with Good syndrome as far as reviewed articles. Thymic carcinoma with severe infection should be examined carefully for co-existence of thymoma, and co-existence of thymoma and thymic carcinoma suggests a close histogenetic relationship between the 2 tumors.


Subject(s)
Carcinoma, Adenosquamous , Paraneoplastic Syndromes , Thymoma , Thymus Neoplasms , Aged , Carcinoma, Adenosquamous/pathology , Carcinoma, Adenosquamous/surgery , Humans , Lymph Node Excision , Male , Mediastinal Neoplasms/secondary , Mediastinal Neoplasms/surgery , Neoplasm Invasiveness , Thymectomy , Thymoma/secondary , Thymoma/surgery , Thymus Neoplasms/pathology , Thymus Neoplasms/surgery
2.
Respirology ; 12(1): 54-62, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17207026

ABSTRACT

BACKGROUND AND OBJECTIVE: The purpose of this study was to obtain an antibody that would be useful for investigating the yet unclear molecular mechanism underlying the differentiation of lung alveolar type I and II cells. METHODS: Monoclonal antibodies were raised against membrane proteins from embryonal day 18.5 rat lungs and characterized by immunoblotting on rat lung lysates at various developmental stages to select an appropriate clone. The antigen of the selected antibody was purified by serial column chromatography and immunoprecipitation and identified by mass spectrometry. RESULTS: 7F9 antibody recognizes a 65-kDa protein that is expressed most prominently from embryonal day 20.5 to postnatal day 1. This protein was identified as a rat protein that is similar to 5730456K23Rik protein. The protein is homologous to human carboxypeptidase-M. Although human carboxypeptidase-M is known as a marker of type I cells, the expression of this rat protein was detected in columnar epithelial cells expressing type II cell markers, SP-C and a lamellar body protein ABCA3, in developing lung. Its expression was detected in alveolar cells lacking T1alpha, a type I cell marker protein, in adult lung. It was also expressed in RLE-6TN cells derived from type II cells. The expression in RLE-6TN cells was down-regulated by transforming growth factor-beta1 and up-regulated by Wnt3a. CONCLUSIONS: 7F9 antibody detects a protein in rat lung cells expressing type II markers. The antibody is a useful tool for studying signalling triggered by transforming growth factor-beta1 and Wnt3a in rat type II cells.


Subject(s)
Antibodies, Monoclonal/immunology , Lung/growth & development , Metalloendopeptidases/immunology , Animals , GPI-Linked Proteins , Gene Expression Regulation, Developmental/physiology , Humans , Immunoblotting , Immunohistochemistry , Lung/immunology , Lung/metabolism , Mass Spectrometry , Rats , Transforming Growth Factor beta1/biosynthesis , Transforming Growth Factor beta1/genetics , Wnt Proteins/biosynthesis , Wnt Proteins/genetics , Wnt3 Protein , Wnt3A Protein
3.
J Med Dent Sci ; 54(1): 103-8, 2007 Mar.
Article in English | MEDLINE | ID: mdl-19845142

ABSTRACT

BACKGROUND: Homer, known as a scaffolding protein that regulates postsynapse signaling in neurons, has been poorly explored in cardiac research. We show the fundamental properties of Homer 1 in mouse heart in association with cardiac ryanodine receptor (RyR), a binding protein of Homer 1. METHODS AND RESULTS: Immunohistochemistry of adult mouse heart with Homer 1 antibody showed striated staining on Z-bands both in atria and ventricles. The interactions between Homer 1 and RyR were confirmed by co-immunoprecipitation assays. Immunostaining of adult isolated cardiomyocytes showed partial co-localization of both proteins. In neonatal primary cultures, targeting of Homer 1 preceded that of RyR in their Z-band arrangement. CONCLUSIONS: Homer 1 binds to RyR in adult mouse heart and precedes RyR in Z-band arrangement in the early postnatal period.


Subject(s)
Carrier Proteins/metabolism , Myocardium/metabolism , Ryanodine Receptor Calcium Release Channel/metabolism , Animals , Animals, Newborn , Cells, Cultured , Homer Scaffolding Proteins , Immunohistochemistry , Immunoprecipitation , Male , Mice , Mice, Inbred ICR , Myocardium/cytology , Protein Binding , Sarcomeres/metabolism
4.
Jpn J Thorac Cardiovasc Surg ; 54(11): 472-6, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17144596

ABSTRACT

OBJECTIVE: A radial artery (RA) graft is frequently used for coronary artery bypass grafting (CABG), but little information exists regarding the early- and mid-term patency associated with the harvesting procedure. The objective of this study is to compare the early- and mid-term patency of the RA graft obtained using non-skeletonized and skeletonized harvesting. METHODS: Altogether, 131 patients and 159 anastomoses were studied. In 85 patients the RA was harvested non-skeletonized (group A: procedures between September 2000 and November 2002), whereas in 46 patients the RA was harvested skeletonized (group B: procedures between November 2002 and April 2004). Angiography results were analyzed before discharge [A: postoperative day (POD) 14.7 +/- 2.9, 75 patients, 90 anastomoses; B: POD 13.7 +/- 1.9, 38 patients, 47 anastomoses], and after 1 year (A: POD 386.8 +/- 149.3, 44 patients, 51 anastomoses; B: POD 267.1 +/- 148.7, 11 patients, 13 anastomoses). RESULTS: There was no difference in patency between the two groups (group A vs group B, 96.7% vs 100%, P = not significant [NS], in the early-term, 96.2% vs 100%, P = NS, in the mid-term). However, the perfect patency rates for groups A and B were 86.7% and 98.1%, respectively, in the early-term (P = 0.034) and 77.5% and 100%, respectively, in the mid-term (P = 0.048). The location and severity of the target vessel did not influence the angiographic results. CONCLUSION: The early- and mid-term patency of RA grafts was excellent, and skeletonized harvesting improved the perfect patency rates at both time points.


Subject(s)
Radial Artery/physiopathology , Radial Artery/surgery , Tissue and Organ Harvesting , Vascular Patency , Aged , Coronary Angiography , Coronary Artery Bypass , Coronary Stenosis/diagnostic imaging , Coronary Stenosis/physiopathology , Coronary Stenosis/surgery , Female , Graft Occlusion, Vascular/diagnostic imaging , Graft Occlusion, Vascular/etiology , Graft Occlusion, Vascular/physiopathology , Humans , Japan , Male , Middle Aged , Radial Artery/diagnostic imaging , Severity of Illness Index , Time Factors , Treatment Outcome
5.
Kyobu Geka ; 59(8 Suppl): 631-6, 2006 Jul.
Article in Japanese | MEDLINE | ID: mdl-16910506

ABSTRACT

The radial artery is a popular arterial conduit for coronary artery bypass grafting (CABG). However, the traditional open harvesting technique requires a long incision, and is therefore associated with some wound complications and cosmetic problems. In order to solve them, we introduced the endoscopic radial artery harvesting (ERAH) at our institution in February 2004 utilizing the VasoView system. The ERAH technique was performed as safely as the traditional open technique and the harvested radial arteries were acceptable as CABG conduits. In particular, patients are satisfied with the excellent cosmetic results of the procedure. Herein, we focus surgical technique, complications of ERAH and ways to prevent them by describing our initial experience and short-term clinical follow-up of the ERAH patients.


Subject(s)
Endoscopy/methods , Radial Artery/transplantation , Tissue and Organ Harvesting/methods , Coronary Artery Bypass , Humans , Transplantation, Autologous
6.
Transplantation ; 81(12): 1700-7, 2006 Jun 27.
Article in English | MEDLINE | ID: mdl-16794537

ABSTRACT

BACKGROUND: Arachidonic acid metabolites and platelet-activating factor (PAF) are potentially involved in ischemia-reperfusion (IR) lung injury. A key enzyme regulating their metabolism is cytosolic phospholipase A2 (cPLA2). Arachidonyl trifluoromethyl ketone (AACOCF3) is reported to be a potent cPLA2 inhibitor. In the present study, we hypothesized that pharmacological inhibition of cPLA2 might ameliorate IR lung injury. METHODS: To test the hypothesis, we examined the effects of AACOCF3 in an isolated rat lung model. Three groups were defined (n=6, each): in the vehicle group, lungs were perfused for 2 hours without an ischemic period. In the ischemic groups, 20 mg/kg of AACOCF3 (AACOCF3 group) or saline (control group) was i.v. administered 15 min before lung harvest. Lungs were flushed with LPD solution, cold-stored 18 hours, and reperfused for 2 hours. RESULTS: IR increased cPLA2 activity mainly via alveolar macrophages, sPLA2 activity, thromboxane and leukotriene formation, and the expression of PAF receptor, whereas AACOCF3 treatment significantly reduced all of these. Compared to the vehicle group, the wet-to-dry ratio, proteins in BAL, and MPO activity increased significantly by twofold, fourfold, and threefold, respectively. Furthermore, the PO2 dropped from 615.7+/-31.2 to 452.1+/-30.9 mmHg at the end of reperfusion (P<0.001). AACOCF3 treatment maintained the PO2 at a level similar to the vehicle group throughout reperfusion and reduced significantly the alveolar-capillary leakage, edema formation, and neutrophil extravasation. CONCLUSION: Pharmacological inhibition of the cPLA2 cascade decreases bioactive lipid formation and attenuates IR-induced lung injury.


Subject(s)
Arachidonic Acids/pharmacology , Disease Models, Animal , Lung/drug effects , Lung/enzymology , Phospholipases A/antagonists & inhibitors , Reperfusion Injury/prevention & control , Animals , Eicosanoids/biosynthesis , Group IV Phospholipases A2 , Group VI Phospholipases A2 , In Vitro Techniques , Lung/blood supply , Lung Transplantation , Male , Neutrophils , Phospholipases A/metabolism , Phospholipases A2 , Phosphorylation , Platelet Membrane Glycoproteins/metabolism , Rats , Rats, Sprague-Dawley , Receptors, G-Protein-Coupled/metabolism , Reperfusion Injury/drug therapy
7.
Psychiatry Clin Neurosci ; 60(3): 277-82, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16732742

ABSTRACT

The aim of the present study was to identify clinical signs detective of the postoperative delirium at the early stage for nursing management. A total of 66 inpatients undergoing cardiac surgery were interviewed using the Delirium Rating Scale (DRS) and NEECHAM Confusion Scale (NCS) preoperatively and on days 1 and 3 postoperatively. The mean onset of delirium occurred on postoperative day 1.3. Development of delirium was detected early by cognitive impairments in the DRS subscales of perceptual disturbance, hallucination, and cognitive status, and the NCS subscales of attention, command, orientation, and verbal skill. These results suggest that assessment of cognitive status on postoperative day is an important strategy in the early detection of postoperative delirium.


Subject(s)
Confusion/diagnosis , Delirium/diagnosis , Nursing Assessment/methods , Postoperative Complications/diagnosis , Early Diagnosis , Female , Humans , Male , Middle Aged , Perioperative Nursing , Surgery Department, Hospital , Thoracic Surgery
8.
Jpn J Thorac Cardiovasc Surg ; 54(1): 3-10, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16482929

ABSTRACT

OBJECTIVES: Despite the long-term benefit, the operative results of conventional coronary artery bypass grafting for chronic hemodialysis patients remain unsatisfactory. The efficacy of off-pump coronary artery bypass grafting for hemodialysis patients is yet to be determined. The purpose of this study was to investigate the postoperative physiology of off-pump coronary artery bypass grafting for hemodialysis patients. METHODS: Twenty-five hemodialysis cases who underwent isolated coronary artery bypass grafting were reviewed. Fifteen of these patients underwent off-pump coronary artery bypass grafting (off-group) and 10 underwent on-pump coronary artery bypass grafting (on-group). Comparisons were made in cardiac function (cardiac index and stroke volume index), respiratory function (AaDO2), hemodialysis management (blood urea nitrogen, creatinine, right atrial pressure, pulmonary wedge pressure), and bleeding tendency (postoperative blood loss and blood transfusion). RESULTS: There was no operative mortality, but 3 major postoperative complications occurred (2 sternal wound infections in the off-group and 1 pneumonia in the on-group). There was no difference in cardiac index or stroke volume index. AaDO2 was significantly lower in the off-group. Plasma concentrations of blood urea nitrogen and creatinine were similar between groups. Right atrial pressure was lower and pulmonary wedge pressure tended to be lower in the off-group. Postoperative bleeding and blood transfusion were similar between groups. CONCLUSION: Our study confirmed that off-pump coronary artery bypass grafting is feasible for hemodialysis patients. Physiologic data showed that off-pump coronary artery bypass grafting might be effective in preserving postoperative lung oxygenation.


Subject(s)
Cardiopulmonary Bypass , Coronary Artery Bypass , Coronary Artery Disease/surgery , Hemodynamics , Renal Dialysis , Aged , Coronary Artery Bypass, Off-Pump , Coronary Artery Disease/physiopathology , Female , Humans , Kidney Failure, Chronic/physiopathology , Kidney Failure, Chronic/therapy , Male , Middle Aged , Treatment Outcome
9.
Med Sci Monit ; 12(2): BR51-6, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16449942

ABSTRACT

BACKGROUND: Ischemia-reperfusion injury of the lungs seems to be initiated by the activation of alveolar macrophages, and mediated by matrix metalloproteinases (MMP)s, although their roles have not been fully elucidated. Therefore, we used a novel MMP inhibitor (ONO-4817) with high affinities for MMP-2 and MMP-9 to investigate the roles of MMPs in reperfusion injury of the lungs. MATERIAL/METHODS: After 18 h of cold ischemia, isolated rat lungs were ventilated and reperfused. Lungs without ischemia served as controls. Lungs were reperfused with fresh blood with or without the MMP inhibitor for 120 min at 37 degrees C. RESULTS: The oxygenation capacity of lungs after ischemia deteriorated progressively during 120 min of reperfusion, but was preserved by the MMP inhibitor (p<0.05). The histopathology of the lungs after ischemia-reperfusion showed interstitial edema accompanied by neutrophil migration, and the number of neutrophils, but not macrophages, in the broncho-alveolar lavage increased to more than two-fold the value in control lungs without ischemia (p<0.01). These changes were attenuated by the MMP inhibitor (p<0.01). Similarly, an increase in the tissue malondialdehyde level in lungs after ischemia-reperfusion was ameliorated by the MMP inhibitor (p<0.01). The expressions of CD11c and CD31 adhesion molecules in extracted alveolar macrophages increased in lungs after ischemia-reperfusion compared with control lungs without ischemia, and the MMP inhibitor had no obvious effect. CONCLUSIONS: Our data show that ONO-4817 prevented neutrophil migration into the interstitial space and alveolus in the lungs, and reduced the production of oxygen free radicals, suggesting that this is an important mechanism in reperfusion injury.


Subject(s)
Lung Injury , Lung/drug effects , Matrix Metalloproteinase Inhibitors , Phenyl Ethers/pharmacology , Protease Inhibitors/pharmacology , Reperfusion Injury/enzymology , Reperfusion Injury/prevention & control , Animals , CD11c Antigen/metabolism , In Vitro Techniques , Lung/pathology , Lung/physiopathology , Macrophages, Alveolar/immunology , Macrophages, Alveolar/pathology , Male , Neutrophils/pathology , Platelet Endothelial Cell Adhesion Molecule-1/metabolism , Rats , Rats, Sprague-Dawley , Reactive Oxygen Species/metabolism , Reperfusion Injury/pathology , Reperfusion Injury/physiopathology
10.
Eur J Cardiothorac Surg ; 29(3): 304-11, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16427299

ABSTRACT

OBJECTIVE: Increased microvascular permeability and extravasation of inflammatory cells are key events in ischemia-reperfusion (IR) injury. We hypothesized that edaravone, a free radical scavenger, is able to attenuate IR lung injury by decreasing oxidative stress and phospholipase A(2) (PLA(2)) activation, which otherwise may lead to lung injury through PAF receptor (PAF-R) activation. METHODS: We used an isolated rat lung model. Five groups were defined (n=7, each): in the sham and vehicle group, lungs were immediately washed after thoracotomy or perfused for 2h without an ischemic period, respectively. In the ischemic groups, 10mg/kg of MCI-186 (edavorane group), 1mg/kg of PAF-R inhibitor (ABT-491 group) or saline (control group) were i.v. administered 20 min before harvest. Lungs were flushed with LPD solution, stored at 4 degrees C for 18 h, and reperfused for 2h. RESULTS: Compared to vehicle group, IR significantly decreased the PO(2) level and increased the wet-to-dry ratio, proteins in bronchoalveolar lavage (BAL), and myeloperoxidase (MPO) activity in the control group, while edaravone treatment maintained the PO(2) similar to the vehicle group and significantly reduced edema formation and neutrophil extravasation. Consistently, IR significantly increased lipid peroxidation, cytosolic-PLA(2) activity mainly via alveolar macrophages, soluble-PLA(2) activity, leukotriene B(4), and PAF-R expression in control lungs, together with a decreased PAF acetylhydrolase (PAF-AH) activity. Edaravone significantly reduced all of these, but increased PAF-AH activity. Furthermore, pharmacological inhibition of the PAF-R attenuated IR injury resembling edaravone action. CONCLUSION: Edaravone attenuates lung IR injury by suppressing oxidative damage and PLA(2) activation, which otherwise partially mediates edema formation and neutrophil extravasation through PAF-R activation.


Subject(s)
Antipyrine/analogs & derivatives , Cold Ischemia , Free Radical Scavengers/therapeutic use , Lung/blood supply , Phospholipases A/metabolism , Reperfusion Injury/prevention & control , Animals , Antipyrine/therapeutic use , Bronchoalveolar Lavage Fluid/chemistry , Disease Models, Animal , Edaravone , Edema/prevention & control , Enzyme Activation , Lipid Peroxidation/drug effects , Male , Organ Culture Techniques , Organ Preservation/methods , Oxidative Stress/drug effects , Oxygen/blood , Rats , Rats, Sprague-Dawley , Reperfusion Injury/etiology , Reperfusion Injury/metabolism
11.
J Card Surg ; 21(1): 102-14; 115, 2006.
Article in English | MEDLINE | ID: mdl-16426364

ABSTRACT

The radial artery (RA) is gaining popularity as a bypass conduit for coronary artery bypass grafting, and its impact on clinical practice has been extensively explored. In the present article, we provide a review of postoperative hand circulation, vascular biological characteristics of the RA graft, the efficacy of vasodilator therapies, and mid-term clinical results of use of the RA graft. Fundamental studies revealed excellent vascular biological characteristics of the RA graft as a living arterial conduit, making it almost equivalent to the internal thoracic artery (ITA) graft. Clinical studies have yielded encouraging mid-term results. Most studies reported in favor of the RA graft over the saphenous vein graft with regard to patency rate, freedom from cardiac events, and survival. However, superiority of either the RA or right ITA graft has not been conclusively determined. The long-term results of RA grafts remain unknown, but at present, supplementary use of an RA graft with a left ITA graft appears feasible for CABG.


Subject(s)
Coronary Artery Bypass/methods , Coronary Disease/surgery , Radial Artery/transplantation , Vasoconstriction/physiology , Angiography , Endothelium, Vascular/physiology , Humans , Radial Artery/diagnostic imaging , Radial Artery/physiology , Treatment Outcome
12.
Innovations (Phila) ; 1(3): 126-30, 2006.
Article in English | MEDLINE | ID: mdl-22436648

ABSTRACT

OBJECTIVE: : To accomplish successful multivessel off-pump coronary artery bypass grafting, safe, reproducible, and effective exposure of all coronary territories is essential. For this purpose, we developed a new, simple, multisuction cardiac positioner. METHODS: : This new cardiac positioner consists of 3 small independent suction cups and suction tubes made of silicone. Unlike an apical suction cardiac positioner, this positioner has no arm. The suction cups can be applied with negative pressure of 300 mm Hg to various surfaces of the ventricle, including not only the apex but also the lateral, inferior, and right ventricular walls, according to surgeon preference. We applied this positioner in 15 clinical multivessel off-pump coronary artery bypass procedures. RESULTS: : In all cases, all target vessels including those on the lateral or inferior wall were successfully exposed and grafted without hemodynamic compromise. Surgical exposure, especially on the lateral and inferior walls, was quite similar to that of conventional coronary artery bypass graft procedures performed during cardiopulmonary bypass. CONCLUSIONS: : The multisuction cardiac positioner provided reproducible and easy access in multivessel off-pump coronary artery bypass surgery. This simple, variable, and inexpensive cardiac positioner may be used as a new tool to aid in the performance of successful multivessel off-pump coronary artery bypass surgery.

13.
J Med Dent Sci ; 52(2): 101-7, 2005 Jun.
Article in English | MEDLINE | ID: mdl-16187615

ABSTRACT

Despite wide spread use of the radial artery (RA) graft for coronary artery bypass grafting, the change of hand circulation after RA harvest has not been fully clarified. Severe hand ischemia such as resting pain or gangrene is a rare complication and has been reported in 4 patients. These cases resulted from occlusive artery disease in forearm, which should be carefully explored before RA harvest. Incidence of mild hand ischemia such as hand claudication or fatigue is unknown, but our study suggested that around 10% of the patients developed mild hand ischemia after RA harvest. The blood flow to the forearm territory was decreased by 20% after RA harvest despite the compensatory dilatation of ulnar artery. The presence of low perfusion in the affected hand has been pointed out in some studies. We reported the decreased tissue oxygenation of the affected hand during hand grip exercise. The Allen test is the most popular preoperative screening method, but is associated with considerable numbers of false-positive and false-negative results. Full length scanning of ulnar artery by ultrasonography seems to have a lower false-positive rate. But further clinical experience is necessary to establish a more reliable screening method.


Subject(s)
Coronary Artery Bypass , Hand/blood supply , Ischemia/etiology , Radial Artery/transplantation , Tissue and Organ Harvesting/adverse effects , Forearm/blood supply , Hand Strength , Humans , Plethysmography , Regional Blood Flow , Ulnar Artery/diagnostic imaging , Ultrasonography, Doppler
14.
Clin Cancer Res ; 11(18): 6495-504, 2005 Sep 15.
Article in English | MEDLINE | ID: mdl-16166425

ABSTRACT

PURPOSE: We showed previously estrogen receptor (ER) alpha as an independent prognostic marker in human thymoma. Estrogen sulfotransferase (EST), steroid sulfatase (STS), 17beta-hydroxysteroid dehydrogenase (17beta-HSD), and aromatase are considered to play important roles in hormone metabolism of estrogen-dependent tumors. EXPERIMENTAL DESIGN: We examined estrogen production using primary cultures of human thymoma epithelial cells (TEC), intratumoral estradiol (E(2)) concentrations, and status of these enzymes above using immunohistochemistry or semiquantitative reverse transcription-PCR. We then correlated these findings with clinicopathologic variables and/or clinical outcome in 132 patients. RESULTS: E(2) inhibited cell proliferation via ERalpha in TEC, which synthesized estrone and E(2). Intratumoral E(2) concentrations were inversely correlated with EST, positively correlated with STS or 17beta-HSD type 1, and significantly higher in lower-grade or early-stage thymoma. EST status was positively correlated with tumor size, clinical stage, histologic differentiation, and Ki-67 labeling index and significantly associated with adverse clinical outcome and turned out to be a potent independent prognostic factor. STS and/or 17beta-HSD type 1 status was inversely correlated with Ki-67 labeling index and associated with lower histologic grade or early clinical stages. CONCLUSIONS: E(2) inhibits proliferation of TEC through ERalpha, which suggests that E(2) may be effective in treatment of thymoma, especially inoperable tumor, possibly through suppressing its cell proliferation activity. EST status is a potent prognostic factor in thymoma through inactivating estrogens. In situ estrogen synthesis through intracrine mechanism therefore may play important roles in tumorigenesis and/or development of thymoma through regulation of cell proliferation in an intracrine manner.


Subject(s)
Cell Proliferation/drug effects , Estrogens/pharmacology , Thymoma/pathology , Thymus Neoplasms/pathology , 17-Hydroxysteroid Dehydrogenases/genetics , 17-Hydroxysteroid Dehydrogenases/metabolism , Adult , Aged , Aromatase/genetics , Aromatase/metabolism , Dose-Response Relationship, Drug , Epithelial Cells/drug effects , Epithelial Cells/metabolism , Epithelial Cells/pathology , Estradiol/biosynthesis , Estrogen Receptor alpha/metabolism , Estrogens/biosynthesis , Estrone/biosynthesis , Female , Humans , Immunohistochemistry , Male , Middle Aged , Multivariate Analysis , Neoplasm Staging , RNA, Messenger/genetics , RNA, Messenger/metabolism , Receptors, Progesterone/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Steryl-Sulfatase/genetics , Steryl-Sulfatase/metabolism , Sulfotransferases/genetics , Sulfotransferases/metabolism , Survival Analysis , Thymoma/genetics , Thymoma/metabolism , Thymus Neoplasms/genetics , Thymus Neoplasms/metabolism , Tumor Cells, Cultured
15.
Ann Thorac Surg ; 80(3): 1137-9, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16122517

ABSTRACT

Coronary artery occlusion during off-pump coronary artery bypass grafting may lead to mechanical trauma of the arterial wall. My colleagues and I describe a safe coronary artery occlusion technique in off-pump bypass grafting that uses a new spring-equipped tourniquet, which enables precise adjustment of the least force necessary to occlude the coronary flow. This prevents snare-induced vessel wall damage.


Subject(s)
Coronary Artery Bypass, Off-Pump/instrumentation , Coronary Artery Bypass, Off-Pump/methods , Tourniquets , Coronary Artery Bypass, Off-Pump/adverse effects , Coronary Stenosis/etiology , Equipment Design , Humans , Treatment Outcome
16.
Eur J Cardiothorac Surg ; 28(4): 581-7, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16125404

ABSTRACT

OBJECTIVE: Ischemia-reperfusion injury is a major factor in the early phase of lung transplantation. We hypothesized that aprotinin, a nonspecific serine protease inhibitor, attenuates ischemia-reperfusion lung injury by inhibiting the inflammatory response and suppressing NADPH oxidase. METHODS: We used an isolated rat lung model to test the above. A Control group was immediately perfused with fresh heparinized allogeneic blood after lung harvest without an ischemic period. Study lungs were flushed with low-potassium dextran (LPD) solution and stored for 18h at 4 degrees C then divided into two groups: the LPD group was flushed with LPD solution only, and the LPD+A group was flushed with LPD solution +200KIU/ml aprotinin. Lungs in all three groups were then reperfused with fresh heparinized allogeneic blood for 120min at 37 degrees C. RESULTS: Throughout reperfusion, PO(2) levels in the LPD+A group were similar to those in the Control group; although in the LPD group, PO(2) levels were significantly lower (P<0.05). Tissue MDA levels were significantly higher in the LPD group than the Control and LPD+A groups (P<0.05). IL-8 levels were significantly higher in the LPD group than the Control group (P<0.05), while in the LPD+A group they were similar to those in the Control group. Histological evaluation showed interstitial edema accompanied by neutrophil extravasation in the LPD group, whereas this effect was modest in the LPD+A group. An additional study of ischemia-reperfusion in an alveolar macrophage culture showed that the activitvation of NADPH oxidase, and translocation of p47(phox) from the cytosol to the membrane were suppressed in aprotinin group. CONCLUSIONS: Aprotinin attenuates ischemia-reperfusion lung injury by inhibiting the early inflammatory response, neutrophil extravasation and the production of oxygen free radicals through inhibition of the activation of the NADPH oxidase. The inhibition of p47(phox) translocation in alveolar macrophage seemed involved in this mechanism of aprotinin.


Subject(s)
Aprotinin/therapeutic use , Lung Transplantation/methods , Reperfusion Injury/drug therapy , Serine Proteinase Inhibitors/therapeutic use , Animals , Cytokines/analysis , Disease Models, Animal , Gelatin/analysis , Lung/pathology , Lung/physiopathology , Macrophages/enzymology , Male , Malondialdehyde/analysis , NADP/metabolism , Organ Preservation/methods , Pulmonary Alveoli/enzymology , Rats , Rats, Sprague-Dawley , Reperfusion/methods , Reperfusion Injury/etiology , Reperfusion Injury/physiopathology , Time Factors
17.
EMBO J ; 24(14): 2590-601, 2005 Jul 20.
Article in English | MEDLINE | ID: mdl-15990869

ABSTRACT

The c-myc proto-oncogene encodes a transcription factor that promotes cell cycle progression and cell proliferation, and its deficiency results in severely retarded proliferation rates. The ATF3 stress response gene encodes a transcription factor that plays a role in determining cell fate under stress conditions. Its biological significance in the control of cell proliferation and its crosstalk regulation, however, are not well understood. Here, we report that the serum response of the ATF3 gene expression depends on c-myc gene and that the c-Myc complex at ATF/CREB site of the gene promoter plays a role in mediating the serum response. Intriguingly, ectopic expression of ATF3 promotes proliferation of c-myc-deficient cells, mostly by alleviating the impeded G1-phase progression observed in these cells, whereas ATF3 knockdown significantly suppresses proliferation of wild-type cells. Our study demonstrates that ATF3 is downstream of the c-Myc signaling pathway and plays a role in mediating the cell proliferation function of c-Myc. Our results provide a novel insight into the functional link of the stress response gene ATF3 and the proto-oncogene c-myc.


Subject(s)
Cell Proliferation , Proto-Oncogene Proteins c-myc/metabolism , Serum/physiology , Transcription Factors/genetics , Activating Transcription Factor 2 , Activating Transcription Factor 3 , Animals , Cell Line , Cell Line, Transformed , Cyclic AMP Response Element-Binding Protein/metabolism , Extracellular Signal-Regulated MAP Kinases/metabolism , G1 Phase/physiology , Promoter Regions, Genetic , Proto-Oncogene Proteins c-jun/metabolism , Rats , Stress, Physiological/genetics , Transcription Factors/metabolism
18.
Hum Mol Genet ; 14(8): 997-1007, 2005 Apr 15.
Article in English | MEDLINE | ID: mdl-15746151

ABSTRACT

Genome-wide screening of DNA copy number aberrations in 27 cell lines derived from non-small cell lung cancers (NSCLCs), using a custom-made comparative genomic hybridization (CGH)-array, identified a homozygous deletion of the deleted in bladder cancer 1 gene (DBC1) in one cell line. Homozygous deletion of DBC1, located at 9q33.1, was also observed in two of 53 primary NSCLC tumors examined. Moreover, 21 of the other 26 cell lines showed complete loss of DBC1 expression, although normal lung tissues express this gene, and treatment with 5-aza-2'-deoxycytidine restored expression of DBC1. Hypermethylation in part of a CpG island around the exon 1 of DBC1 has been reported in urothelial cancers, but the potential association between methylation and expression status was never clarified in that disease. In our experiments, a different part of the same CpG island showed promoter activity in vitro and was frequently methylated in our cell lines and primary tumors of NSCLC, where methylation status correlated inversely with gene expression. Among our primary NSCLC cases, methylation of the DBC1 promoter occurred more frequently in men, elderly patients and smokers than in women, younger patients and nonsmokers respectively, but it was not correlated with tumor stage or histology. Exogenous overexpression of DBC1 in NSCLC cell lines lacking its expression inhibited cell growth. Our results provide the first evidence that DBC1 is a likely tumor suppressor for NSCLC; silencing of the gene through homozygous deletion or methylation of its promoter region may be associated with progression of this disease.


Subject(s)
Azacitidine/analogs & derivatives , Carcinoma, Non-Small-Cell Lung/genetics , Gene Silencing , Tumor Suppressor Proteins/genetics , Aged , Antimetabolites, Antineoplastic/pharmacology , Azacitidine/pharmacology , Carcinoma, Non-Small-Cell Lung/metabolism , Cell Cycle Proteins , Chromosomes, Human, Pair 9 , CpG Islands , DNA/drug effects , DNA Methylation , Decitabine , Epigenesis, Genetic , Female , Gene Deletion , Humans , Male , Nerve Tissue Proteins , Promoter Regions, Genetic , Tumor Suppressor Proteins/metabolism
19.
Ann Thorac Surg ; 79(3): 831-5; discussion 835-6, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15734388

ABSTRACT

BACKGROUND: Radial artery grafts are used for coronary artery bypass grafting (CABG), and postoperative antispasm therapy with diltiazem is performed widely. Some investigators have warned that diltiazem administration after cardiac surgery is harmful to renal function. We designed a retrospective study to investigate the renal and hemodynamic effects of the postoperative administration of diltiazem in patients undergoing CABG. METHODS: Subjects were 90 consecutive CABG patients. All were treated with diltiazem during surgery (a 0.1 mg/kg bolus injection followed by continuous infusion at 2 microg x kg(-1) x min(-1)). In the 50 patients (diltiazem group) with a radial artery graft, intravenous diltiazem administration was continued until the oral intake of diltiazem (90 mg/d) was begun to avoid graft spasms. In the remaining 40 patients without a radial artery graft, diltiazem was not continued postoperatively (control group). Postoperative renal function, assessed by serum creatinine level and creatinine clearance, and hemodynamic variables (heart rate, arterial pressure, pulmonary wedge pressure, cardiac index, left ventricular stroke work index) was compared between the two groups. RESULTS: Renal function: Serum creatinine concentrations on postoperative days 1 through 7 were lower, and the endogenous creatinine clearance in the early postoperative period was higher in diltiazem group than in control group, although the differences were not significant. Hemodynamics: Heart rate was lower in diltiazem group than in the control group, but blood pressure, pulmonary wedge pressure, cardiac index, left ventricular stroke work index, and urinary output were similar between the groups. CONCLUSIONS: Our results confirmed that intravenous diltiazem treatment in patients undergoing CABG is not harmful to renal function.


Subject(s)
Coronary Artery Bypass/adverse effects , Diltiazem/therapeutic use , Kidney/drug effects , Kidney/physiology , Spasm/etiology , Spasm/prevention & control , Diltiazem/pharmacology , Female , Hemodynamics/drug effects , Humans , Male , Middle Aged , Radial Artery/transplantation , Retrospective Studies
20.
Hypertension ; 45(3): 419-25, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15699450

ABSTRACT

Using bioinformatic analyses of full-length, enriched human cDNA libraries, we recently identified salusins, multifunctional related peptides ubiquitously expressed in major human tissues. Salusins cause transient and profound hypotension when injected intravenously to rats, the hypotensive effect of salusin-beta being especially striking. However, the mechanisms of this hypotensive action remain elusive. To determine whether salusins modulate cardiac function in rats, we studied serial changes of systemic hemodynamics and functions of isolated perfused working and nonworking hearts before and after salusin administration. Intravenous salusin-beta administration to intact anesthetized rats caused a temporary rapid, profound decrease in aortic blood flow concomitantly with hypotension and bradycardia without affecting systemic vascular resistance. Salusin-beta-induced hypotension and bradycardia were completely blocked by pretreatment with atropine, a muscarinic receptor antagonist, but not by propranolol. In isolated perfused working rat hearts, salusin-beta significantly decreased cardiac output, aortic flow, and stroke work. However, it did not affect coronary flow in isolated working and nonworking hearts. Our results indicate that salusins induce potent hypotension via negative inotropic and chronotropic actions. Salusin-beta promotes its actions by facilitating vagal outflows to the heart, whereas the negative inotropism of salusin-beta is also mediated via a direct myotropic effect.


Subject(s)
Adenosine Triphosphatases/pharmacology , Heart/drug effects , Adenosine Triphosphatases/chemical synthesis , Animals , Aorta/physiology , Bradycardia/chemically induced , Cardiac Output/drug effects , Humans , Hypotension/chemically induced , In Vitro Techniques , Injections, Intravenous , Intercellular Signaling Peptides and Proteins , Male , Myocardial Contraction/drug effects , Perfusion , Rats , Rats, Sprague-Dawley , Regional Blood Flow/drug effects , Stroke Volume/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...